Leveraging Advanced In Silico Techniques in Early Drug Discovery: A Study of Potent Small-Molecule YAP-TEAD PPI Disruptors.

Awoonor-Williams, Ernest; Dickson, Callum J; Furet, Pascal; Golosov, Andrei A; Hornak, Viktor

Awoonor-Williams, Ernest; Dickson, Callum J; Furet, Pascal; Golosov, Andrei A; Hornak, Viktor.

Affiliation

Awoonor-Williams E; Novartis Institutes for BioMedical Research, 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Dickson CJ; Novartis Institutes for BioMedical Research, 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Furet P; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.
Golosov AA; Novartis Institutes for BioMedical Research, 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Hornak V; Novartis Institutes for BioMedical Research, 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

J Chem Inf Model ; 63(8): 2520-2531, 2023 04 24.

Article de En | MEDLINE | ID: mdl-37010474

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peptides / Facteurs de transcription Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: J Chem Inf Model Sujet du journal: INFORMATICA MEDICA / QUIMICA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google